Global Respiratory Care Devices Market to Grow at a Substantial Growth Rate of ~8% by 2034 | DelveInsight

The respiratory care devices market is primarily driven by several key factors. The rising prevalence of chronic respiratory conditions such as COPD, asthma, sleep apnea, and acute respiratory infections has significantly increased the demand for efficient respiratory treatment solutions. Additionally, the growing preference for home healthcare has boosted the need for accessible and ongoing respiratory support beyond hospital settings. Furthermore, ongoing technological advancements and new product innovations in respiratory care devices are improving treatment effectiveness and patient outcomes, thereby contributing to market growth.

New York, USA, April 22, 2026 (GLOBE NEWSWIRE) — Global Respiratory Care Devices Market to Grow at a Substantial Growth Rate of ~8% by 2034 | DelveInsight

The respiratory care devices market is primarily driven by several key factors. The rising prevalence of chronic respiratory conditions such as COPD, asthma, sleep apnea, and acute respiratory infections has significantly increased the demand for efficient respiratory treatment solutions. Additionally, the growing preference for home healthcare has boosted the need for accessible and ongoing respiratory support beyond hospital settings. Furthermore, ongoing technological advancements and new product innovations in respiratory care devices are improving treatment effectiveness and patient outcomes, thereby contributing to market growth.

DelveInsight’s Respiratory Care Devices Market Insights report provides the current and forecast market analysis, individual leading respiratory care devices companies’ market shares, challenges, respiratory care devices market drivers, barriers, trends, and key respiratory care devices companies in the market.

Respiratory Care Devices Market Summary

• 2025 Respiratory Care Devices Market Size: USD 24.3 Billion
• 2034 Projected Respiratory Care Devices Market Size: USD 47.5 Billion
• Respiratory Care Devices Market Growth Rate (2026-2034): ~8% 
• Largest Respiratory Care Devices Market: North America
• Largest Product Type Segment: Ventilators Category within Therapeutic Devices System
• Key Companies in the Respiratory Care Devices Market: Koninklijke Philips N.V., Medtronic, GE Healthcare, Masimo, ResMed, Dragerwerk AG & CO. KGaA, Fisher & Paykel Healthcare, Hamilton Medical, Getinge AB, Air Liquide Medical Systems, Breas Medical AB, Chart Industries, GaleMed Corporation, OMRON Healthcare, A-M Systems, Invacare Corporation, Vyaire Medical, Polymed, Flexicare (Group) Limited, HomeMedix, and others

To read more about the latest highlights related to the respiratory care devices market, get a snapshot of the key highlights @  https://www.delveinsight.com/sample-request/respiratory-care-devices-market

Key Factors Contributing to the Rise in Growth of the Respiratory Care Devices Market

• Rising Burden of Chronic Respiratory Diseases: The escalating global prevalence of chronic respiratory conditions, including COPD, asthma, and sleep apnea, remains the single most powerful driver of market growth.
• Air Pollution, Urbanization & Lifestyle Factors: Rapid urbanization and industrialization have significantly deteriorated air quality worldwide, directly increasing the incidence of respiratory illnesses.
• Aging Population & Preterm Births: A rapidly aging global population is inherently more susceptible to respiratory conditions, driving higher device adoption rates among elderly patients.
• Technological Advancements & Smart Devices: Innovations such as portable nebulizers, smart inhalers, AI-enabled ventilators, and sensor-based monitoring systems are transforming respiratory care delivery.
• Post-COVID-19 Awareness & Demand Surge: The COVID-19 pandemic dramatically heightened global awareness of respiratory health, leading to a significant surge in demand for ventilators, oxygen devices, and related equipment.
• Growing Demand for Home Care Devices: There is a significant shift toward home-based respiratory care, driven by patient preference for comfort, cost reduction, and the aging-in-place trend.
• Healthcare Infrastructure Investment & Government Support: Governments and private entities globally are increasing investment in healthcare infrastructure, specifically funding hospitals, clinics, and specialized respiratory care centers equipped with advanced devices.

Get a sneak peek at the respiratory care devices market dynamics @ Respiratory Care Devices Market Trends

Regional Respiratory Care Devices Market Insights

North America

• North America held the largest share of the respiratory care devices market in 2025, contributing 41% of the global market across all regions. 
• This leading position is attributed to the increasing prevalence of chronic respiratory disorders, including chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and acute respiratory infections. 
• Moreover, the growing preference for home healthcare solutions, along with continuous advancements in easy-to-use and efficient respiratory devices, is further driving demand and strengthening the region’s market leadership.

Europe

• Europe is experiencing significant growth in the respiratory care devices market, driven by the increasing incidence of chronic diseases such as COPD, asthma, sleep apnea, and acute respiratory infections. 
• Alongside this, the growing preference for home-based healthcare and continuous technological advancements is boosting demand for innovative, user-friendly respiratory solutions.

Asia-Pacific

• The Asia Pacific region is witnessing strong expansion in the respiratory care devices market, fueled by the rising incidence of chronic respiratory diseases such as COPD, asthma, sleep apnea, and acute respiratory infections.

To know more about why North America is leading the market growth in the respiratory care devices market, get a snapshot of the Respiratory Care Devices Market Share

Recent Developmental Activities in the Respiratory Care Devices Market

• In July 2025, Synchrony Medical, a medical technology company focused on advancing respiratory care, received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its LibAirty™ Airway Clearance System in the United States.
• In January 2025, Linshom Medical announced that the U.S. Food and Drug Administration had granted 510(k) clearance for the company’s two-piece, wearable respiratory sensor. 

What are Respiratory Care Devices?

Respiratory care devices are medical instruments and equipment designed to assist, monitor, and improve breathing in individuals suffering from acute or chronic respiratory conditions. These devices play a vital role in managing disorders such as asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, pneumonia, and other lung-related illnesses. They include a wide range of products such as ventilators, nebulizers, oxygen concentrators, inhalers, CPAP/BiPAP machines, spirometers, and humidifiers. Respiratory care devices are used across hospitals, clinics, emergency care settings, and increasingly in home healthcare environments to deliver oxygen therapy, support airway management, administer medications, and track lung function. With the rising prevalence of respiratory diseases and growing demand for home-based treatment, these devices have become essential for enhancing patient outcomes and quality of life.

Respiratory Care Devices Market Assessment

• Respiratory Care Devices Market Segmentation
  • Respiratory Care Devices Market Segmentation By Product Type: Therapeutic Devices {Ventilators [Invasive Ventilators and Non-Invasive Ventilators], Positive Airway Pressure (PAP) Devices [Continuous Positive Airway Pressure (CPAP) Devices, Bilevel PAP (BPAP) Devices, and Automatic positive airway pressure (APAP) devices],  Nebulizers [Jet Nebulizers, Ultrasonic Nebulizers, and Mesh Nebulizers] and Others}, Monitoring & Diagnostic Devices {Spirometers [Table Top and Portable], Pulse Oximeters [Fingertip Pulse Oximeters, Handheld Pulse Oximeters, Benchtop Pulse Oximeters, Wearable Pulse Oximeters], Capnography Devices [Side Stream Capnography Devices, Main Stream Capnography Devices, Micro Stream Capnography Devices], Polysomnography Devices [Stationary Devices and Portable Devices], Others}, Airway Management Devices {Endotracheal Tubes, Tracheostomy Tubes, and Others}, and Consumables & Accessories
  • Respiratory Care Devices Market Segmentation By End User: Hospitals and Clinics, Ambulatory Surgical Centers, Homecare Settings and Others
  • Respiratory Care Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the respiratory care devices market are set to emerge as the trendsetter explore @ Respiratory Care Devices Market Analysis

Table of Contents 

Interested in knowing the respiratory care devices market share by 2034? Click to get a snapshot of the Respiratory Care Devices Market Size 

Related Reports

Respiratory Monitoring Devices Market

Respiratory Monitoring Devices Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key respiratory monitoring devices companies, including Koninklijke Philips NV, ResMed, Medtronic plc., GE Healthcare, Draegerwerk, Seimens Healthineers, Nihon Kohden Corporation, Vyaire Medical, Inc., Hamilton Medical, Getinge Inc., BD, Airsep Corporation, Smiths Medical, Masimo, Fisher and Paykel Healthcare, and others.

Chronic Obstructive Pulmonary Disease Treatment Devices Market

Chronic Obstructive Pulmonary Disease Treatment Devices Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key COPD treatment devices companies, including Koninklijke Philips N.V., Omron Healthcare, Inc., Aerogen, GF Health Products, Inc., BMC Medical Co., Ltd., Medtronic, Trudell Medical International, Novartis AG, AstraZeneca, Lupin, Zydus Cadila, Teva Pharmaceutical Industries Ltd, Terumo Corporation, Cipla Inc., Microlife Corporation, Honsun, Promed Technology Co. Limited, HELTMAN Medikal A.S., Pneuma Respiratory, Lepu Medical Technology (Beijing) Co., Ltd., and others.

Chronic Obstructive Pulmonary Disease Market

Chronic Obstructive Pulmonary Disease Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key COPD companies including Genentech, Inc., GlaxoSmithKline, Verona Pharma plc, Regeneron Pharmaceuticals, Sanofi, MedImmune LLC, EpiEndo Pharmaceuticals, Tetherex Pharmaceuticals, AstraZeneca, Chiesi Farmaceutici S.p.A., Synairgen Research Ltd., Mereo Biopharma, Organicell Regenerative Medicine, Pulmotect, Inc., Inmunotek S.L., PULMATRiX, GLENMARK PHARMACEUTICALS LTD, Dimerix Limited, ProterixBio, and others.

Asthma Market

Asthma Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key asthma companies including GlaxoSmithKline, 4D Pharma plc, AstraZeneca, Suzhou Connect Biopharmaceuticals, Avillion, Pearl Therapeutics, ARS Pharmaceuticals, Sinomab, Avalo Therapeutics, Kymab, Sanofi, Cumberland Pharmaceuticals, Genentech, Inc., and others.

Acute Respiratory Distress Syndrome Market

Acute Respiratory Distress Syndrome Market Insights, Epidemiology, and Market Forecast – 2036 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key ARDS companies, including MediciNova, Edesa Biotech, Light Chain Biosciences, Boehringer Ingelheim, Genentech, Windtree Therapeutics, Biomarck Pharmaceuticals, Athersys, Healios, Direct Biologics, Biohaven Pharmaceutical, Arch Biopartners, APEPTICO Forschung und Entwicklung GmbH, Staidson (Beijing) Biopharmaceuticals, Veru, Mesoblast Limited, Avalo Therapeutics, Pluristem Therapeutics, ILTOO Pharma, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

CONTACT: Contact Us Shruti Thakur  [email protected]  +14699457679

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.